Escitalopram grindeks

Package leaflet: Information for the user

Escitalopram Grindeks, 5 mg, film-coated tablets
Escitalopram Grindeks, 10 mg, film-coated tablets
Escitalopram Grindeks, 20 mg, film-coated tablets
Escitalopram
Please read the entire leaflet carefully before taking this medicine, as it contains
important information for the patient.

• Keep this leaflet for future reference.
• If you have any questions, consult your doctor or pharmacist.
• This medicine has been prescribed for a specific individual. Do not share it with others. This medicine may harm other people, even if their symptoms are the same.
• If you experience any adverse reactions, including any not listed in this leaflet, inform your doctor or pharmacist. See section 4.

Table of contents

1. What Escitalopram Grindeks is and what it is used for
2. Important information before taking Escitalopram Grindeks
3. How to take Escitalopram Grindeks
4. Possible side effects
5. How to store Escitalopram Grindeks
6. Contents of the pack and other information

1. What Escitalopram Grindeks is and what it is used for

Escitalopram Grindeks contains the active substance escitalopram. Escitalopram belongs to a group of antidepressant medicines called selective serotonin reuptake inhibitors (SSRIs). These medicines act on the serotonin system in the brain by increasing the level of serotonin.
Escitalopram Grindeks is used to treat depression (major depressive episodes) and anxiety disorders (such as panic disorder with or without agoraphobia, social phobia, generalized anxiety disorder, and obsessive-compulsive disorder).
Improvement in well-being may take several weeks. You should continue taking Escitalopram Grindeks even if it takes some time before your health improves.
If there is no improvement or if your condition worsens, contact your doctor.

2. Important information before taking Escitalopram Grindeks

When not to take Escitalopram Grindeks

• if the patient is allergic to escitalopram or any of the other ingredients of this medicine (listed in section 6).
• if the patient is taking other medicines belonging to a group called MAO inhibitors, containing selegiline (used in the treatment of Parkinson's disease), moclobemide (used in the treatment of depression), or linezolid (an antibiotic).
• if the patient was born with a congenital abnormal heart rhythm or if the patient has experienced an episode of abnormal heart rhythm (visible on ECG; a test assessing heart function).
• if the patient is taking medicines used to treat heart rhythm disorders or medicines that may affect heart rhythm (see section “Escitalopram Grindeks and other medicines”).

Warnings and precautions
Before starting treatment with Escitalopram Grindeks, discuss this with your doctor or
pharmacist. You should tell your doctor if the patient has any other disorders or diseases,
as the doctor should take such information into account. In particular, inform the
doctor:

• if the patient has epilepsy. If seizures occur for the first time or increase in frequency, treatment with Escitalopram Grindeks should be discontinued (see also section 4 “Possible side effects”);
• if the patient has impaired liver or kidney function. Dose adjustment by the doctor may be required;
• if the patient has diabetes. Treatment with Escitalopram Grindeks may affect blood glucose control. Adjustment of insulin and/or oral glucose-lowering medicines may be necessary;
• if the patient has low sodium levels in the blood;
• if the patient has a tendency to bleed easily or bruise easily, or if the patient is pregnant (see “Pregnancy, breastfeeding and fertility”);
• if the patient is undergoing electroconvulsive therapy;
• if the patient has ischemic heart disease;
• if the patient has heart problems or has recently had a heart attack;
• if the patient has a slow resting heart rate and/or if the patient has a salt deficiency due to prolonged severe diarrhoea, vomiting, or use of diuretics (water tablets);
• if the patient experiences rapid or irregular heartbeat, fainting, collapse, or dizziness upon standing, which may indicate an abnormal heart rhythm;
• if the patient has had or currently has eye problems, such as certain types of glaucoma (increased pressure inside the eyeball).

Note
In some patients with bipolar affective disorder, a manic phase may occur. This is characterized by unusual and rapidly changing ideas, unjustified feelings of happiness, and excessive physical activity. If these symptoms occur, consult a doctor.
During the first weeks of treatment, symptoms such as inner restlessness or difficulty sitting or standing still may also occur. If such symptoms appear, inform the doctor immediately.
Medicines such as Escitalopram Grindeks (so-called SSRIs or SNRIs) may cause sexual dysfunction symptoms (see section 4). In some cases, these symptoms persisted after discontinuation of treatment.
Suicidal thoughts and worsening of depression or anxiety disorder
Patients with depression or anxiety disorders may sometimes have thoughts of self-harm or suicide. These may worsen at the beginning of treatment with antidepressants, as their effect takes time—usually about two weeks, but sometimes longer.
Such thoughts are more likely:

• If the patient previously had thoughts of suicide or self-harm.
• If the patient is a young adult. Clinical trial data show an increased risk of suicidal behaviour in patients under 25 years of age with psychiatric disorders who were treated with antidepressants. If at any time the patient experiences thoughts of self-harm or suicide, seek immediate medical help by contacting a doctor or going to hospital. It may be helpful to inform a relative or close friend about the depression or anxiety disorder and ask them to read this leaflet. The patient may ask them

to inform him/her if they notice worsening depression or anxiety or if they are concerned about changes
in the patient’s behaviour.
Children and adolescents
Escitalopram Grindeks is generally not recommended for use in children and adolescents under 18 years of age.
It should also be noted that patients under 18 years of age taking medicines of this class are at increased risk of adverse reactions such as suicide attempts, suicidal thoughts, and hostility (particularly aggression, defiant behaviour, and anger).
Nevertheless, a doctor may prescribe Escitalopram Grindeks to patients under 18 years of age if the doctor considers it to be in their best interest. If a doctor has prescribed Escitalopram Grindeks to a patient under 18 years of age and there is a need to discuss this matter, contact the doctor. If the above-mentioned symptoms develop or worsen in patients under 18 years of age, contact the doctor. Furthermore, the long-term effect of escitalopram on growth, maturation, and cognitive and behavioural development in this age group has not yet been established.
Escitalopram Grindeks and other medicines
Tell your doctor or pharmacist about all medicines the patient is currently taking or has recently taken, as well as any medicines the patient plans to take.
Inform the doctor if the patient is taking any of the following medicines:

• Non-selective monoamine oxidase inhibitors (MAO inhibitors) containing phenelzine, iproniazid, isocarboxazid, nialamide, or tranylcypromine as active substances. If any of these medicines are being taken, wait 14 days before starting Escitalopram Grindeks. After stopping Escitalopram Grindeks, wait 7 days before taking any of these medicines.
• Reversible, selective monoamine oxidase A (MAO-A) inhibitors containing moclobemide (used in the treatment of depression).
• Irreversible monoamine oxidase B (MAO-B) inhibitors containing selegiline (used in the treatment of Parkinson's disease). These increase the risk of adverse effects.
• The antibiotic linezolid.
• Lithium (used in the treatment of manic-depressive psychosis) and tryptophan.
• Imipramine and desipramine (used in the treatment of depression).
• Sumatriptan and similar medicines (used in the treatment of migraine) and tramadol and similar medicines (opioids, used for severe pain). These increase the risk of adverse effects.
• Cimetidine, lansoprazole, and omeprazole (used in the treatment of stomach ulcers), fluconazole (an antifungal medicine), fluvoxamine (an antidepressant), and ticlopidine (used to reduce the risk of stroke). These may increase the blood concentration of escitalopram.
• St John's wort (Hypericum perforatum)—a herbal remedy used for depression.
• Acetylsalicylic acid and non-steroidal anti-inflammatory drugs (painkillers or blood-thinning medicines, known as anticoagulants). These may increase the tendency to bleed.
• Warfarin, dipyridamole, and phenprocoumon (blood-thinning medicines, known as anticoagulants). The doctor will likely check the patient's blood clotting time when starting and stopping treatment with Escitalopram Grindeks to ensure the anticoagulant dose remains appropriate.
• Mefloquine (used in the treatment of malaria), bupropion (used in the treatment of depression), and tramadol (used in the treatment of severe pain) due to a possible risk of lowering the seizure threshold.
• Neuroleptics (medicines used in the treatment of schizophrenia, psychosis) and antidepressants (tricyclic antidepressants and SSRIs) due to a possible risk of lowering the seizure threshold.
• Flecainide, propafenone, and metoprolol (used in cardiovascular disorders), clomipramine and nortriptyline (antidepressants), and risperidone, thioridazine, and haloperidol (antipsychotics). Dose adjustment of Escitalopram Grindeks may be required.
• Medicines that lower potassium or magnesium levels in the blood, as they increase the risk of life-threatening heart rhythm disturbances.

Do not take Escitalopram Grindeks if the patient is taking medicines used
for heart rhythm disorders or medicines that may affect heart rhythm, such as class IA and III antiarrhythmics, antipsychotics (e.g. phenothiazine derivatives, pimozide,
haloperidol), tricyclic antidepressants, certain antibacterial medicines (e.g.
sparfloxacin, moxifloxacin, erythromycin IV, pentamidine, antimalarials,
particularly halofantrine), certain antihistamines (astemizole, hydroxyzine,
mizolastine), etc. If in doubt, consult a doctor.
Escitalopram Grindeks with food, drink and alcohol
Escitalopram Grindeks can be taken with or without food (see section 3 “How to take Escitalopram Grindeks”).
As with many medicines, it is not recommended to combine Escitalopram Grindeks with
alcohol, although no interaction between Escitalopram Grindeks and alcohol is expected.
Pregnancy, breastfeeding and fertility
If the patient is pregnant or breastfeeding, suspects she may be pregnant, or is planning to have
a child, she should consult a doctor or pharmacist before using this medicine. Do not
take Escitalopram Grindeks if the patient is pregnant or breastfeeding, unless the
doctor has discussed the associated risks and benefits with her.
If the patient takes Escitalopram Grindeks during the last 3 months of pregnancy, she should be
aware that the newborn may experience the following symptoms: breathing difficulties, blue skin,
seizures, temperature fluctuations, feeding difficulties, vomiting, low blood glucose levels, muscle
stiffness or floppiness, increased reflex excitability, tremors, shakiness, irritability, lethargy, constant
crying, drowsiness, and difficulty sleeping. If any of these symptoms occur in the newborn, seek
immediate medical attention.
Ensure that the midwife and/or doctor are aware that the patient is taking Escitalopram Grindeks.
Medicines such as Escitalopram Grindeks taken during pregnancy, particularly during the last
3 months, may increase the risk of a serious condition in newborns called persistent pulmonary
hypertension of the newborn (PPHN), causing the baby to breathe faster and appear blue. These
symptoms usually occur within the first 24 hours after birth. If such symptoms occur in the newborn,
contact the midwife and/or doctor immediately.
Taking Escitalopram Grindeks towards the end of pregnancy may increase the risk of heavy
vaginal bleeding shortly after delivery, especially if the patient has previously had blood
clotting disorders. The doctor or midwife should be informed about the use of Escitalopram
Grindeks so they can provide appropriate advice.
If Escitalopram Grindeks is taken during pregnancy, it should never be stopped abruptly.
Escitalopram is expected to pass into breast milk.
Animal studies have shown that citalopram, a medicine similar to escitalopram, reduces sperm quality.
This could theoretically affect fertility, although no effect on fertility has been observed in humans to date.
Driving and operating machinery
Patients are advised not to drive or operate machinery until they know how Escitalopram Grindeks
affects them.
Escitalopram Grindeks contains sodium
This medicine contains less than 1 mmol (23 mg) of sodium per dose, i.e. the medicine is considered "sodium-free".

3. How to take Escitalopram Grindeks

This medicine should always be taken as prescribed by your doctor. If you have any doubts, consult your doctor or pharmacist.

Adults

Depression
The usual recommended dose of Escitalopram Grindeks is 10 mg taken once daily. Your doctor may increase the dose up to a maximum of 20 mg per day.

Panic disorder with agoraphobia
The initial dose of Escitalopram Grindeks is 5 mg taken once daily during the first week of treatment, before increasing the dose to 10 mg per day. The dose may then be increased by your doctor up to a maximum of 20 mg per day.

Social phobia
The usual recommended dose of Escitalopram Grindeks is 10 mg taken once daily. Your doctor may reduce the dose to 5 mg per day or increase it up to a maximum of 20 mg per day, depending on your response to the medicine.

Generalised anxiety disorder
The usual recommended dose of Escitalopram Grindeks is 10 mg taken once daily. Your doctor may increase the dose up to a maximum of 20 mg per day.

Obsessive-compulsive disorder
The usual recommended dose of Escitalopram Grindeks is 10 mg taken once daily. Your doctor may increase the dose up to a maximum of 20 mg per day.

Patients aged 65 years and over
The recommended starting dose of Escitalopram Grindeks is 5 mg taken once daily. Your doctor may recommend increasing the dose to 10 mg per day.

Use in children and adolescents
Escitalopram Grindeks is not generally recommended for use in children and adolescents. For more information, see section 2 "Warnings and precautions".

Renal impairment
Caution should be exercised in patients with severe renal impairment. The medicine should be used according to the doctor's instructions.

Hepatic impairment
Patients with impaired liver function should not take more than 10 mg per day. The medicine should be taken as directed by the doctor.

Patients who are poor metabolisers of drugs via the CYP2C19 isoenzyme
Patients with this known genotype should not receive more than 10 mg per day. The medicine should be taken as directed by the doctor.

How to take the tablets
Escitalopram Grindeks tablets can be taken with or without food. Swallow the tablets with water. Do not chew them, as they have a bitter taste.

If necessary, the tablets may be divided by first placing them on a flat surface with the score line facing upwards. The tablets can then be broken by pressing each end with both index fingers, as shown in the illustration.

Only the 10 mg and 20 mg tablets can be divided into equal doses.

Duration of treatment
You may not start to feel better until after several weeks of treatment. Continue taking Escitalopram Grindeks even if it takes some time before you feel improvement. Do not change the dose without first consulting your doctor.

Continue taking Escitalopram Grindeks for as long as your doctor recommends. Stopping treatment too early may lead to a recurrence of symptoms. It is recommended to continue treatment for at least 6 months after regaining good well-being.

Taking more Escitalopram Grindeks than prescribed
If you have taken more Escitalopram Grindeks than prescribed, contact your doctor or the nearest hospital emergency department immediately. Do this even if you do not feel unwell. Some symptoms of overdose may include dizziness, tremors, agitation, seizures, coma, nausea, vomiting, cardiac arrhythmias, low blood pressure, and disturbances in water and electrolyte balance.

Take the medicine pack with you when visiting the doctor or hospital.

If you miss a dose of Escitalopram Grindeks
Do not take a double dose to make up for a missed dose. If you forget to take a dose and remember before going to bed, take it immediately. Continue taking the medicine as usual the next day. If you remember about the missed dose during the night or the following day, skip the missed dose and take the next dose at the usual time.

Stopping treatment with Escitalopram Grindeks
Do not stop taking Escitalopram Grindeks unless your doctor advises you to do so. After completing treatment, it is usually recommended to gradually reduce the dose of Escitalopram Grindeks over several weeks.

After stopping Escitalopram Grindeks, especially if stopped abruptly, you may experience withdrawal symptoms. These are common when stopping treatment with Escitalopram Grindeks. The risk is greater if Escitalopram Grindeks has been taken for a long time, at high doses, or if the dose was reduced too quickly. In most people, symptoms are mild and resolve spontaneously within two weeks. However, in some patients, symptoms may be more severe or last longer (2–3 months or more). If you experience severe withdrawal symptoms after stopping Escitalopram Grindeks, contact your doctor. Your doctor may recommend restarting the tablets and tapering them more slowly.

Withdrawal symptoms include: dizziness (unsteady gait, balance disturbances), tingling sensations, burning sensations, and (less commonly) electric shock-like sensations, including in the head; sleep disturbances (vivid dreams, nightmares, insomnia); feeling anxious; headache; nausea; sweating (including night sweats); feeling restless or agitated; tremors (shakiness); feeling disoriented or confused; emotional instability or irritability; diarrhoea (loose stools); visual disturbances; palpitations (fluttering or pounding heartbeats).

If you have any further questions about the use of this medicine, consult your doctor or pharmacist.

4. Possible adverse reactions

Like any medicine, this medicine may cause adverse reactions, although not everyone will experience them.
Adverse reactions usually subside within a few weeks of treatment. It should be remembered that some
of these reactions may also be symptoms of the illness itself and will resolve as the patient's condition improves.
If any of these adverse reactions occur during treatment, you should
contact your doctor or go to hospital immediately:
Uncommon (may occur in 1 out of 100 people):

• Unusual bleeding, including gastrointestinal bleeding.
• Swelling of the skin, tongue, lips, larynx or face, urticaria, or difficulty breathing or swallowing (severe allergic reaction).
• High fever, agitation, confusion, tremors, and sudden muscle contractions, which may be symptoms of a rare condition called serotonin syndrome.
• Difficulty in passing urine.
• Seizures, see also section "Warnings and precautions".
• Yellowing of the skin and whites of the eyes, indicating impaired liver function/hepatitis.
• Rapid or irregular heartbeat, fainting, which may be symptoms of a life-threatening condition called torsade de pointes.
• Thoughts of harming yourself or of suicide, see also section "Warnings and precautions".
• Sudden swelling of the skin or mucous membranes (angioedema).

In addition to those listed above, the following adverse reactions have also been reported:
Very common (may occur in more than 1 out of 10 people):

• Nausea.
• Headache.

Common (may occur in up to 1 out of 10 people):

• Nasal congestion or cold symptoms (sinusitis).
• Decreased or increased appetite.
• Anxiety, restlessness, unusual dreams, difficulty falling asleep, drowsiness, dizziness, yawning, tremors, tingling sensations in the skin.
• Diarrhoea, constipation, vomiting, dry mouth.
• Excessive sweating.
• Muscle and joint pain.
• Sexual dysfunction (delayed ejaculation, erectile dysfunction, decreased libido, and difficulty achieving orgasm in women).
• Feeling of fatigue, fever.
• Weight gain.

Uncommon (may occur in up to 1 out of 100 people):

• Urticaria, rash, itching.
• Teeth grinding, agitation, nervousness, panic attack, disorientation.
• Sleep disturbances, taste disturbances, fainting (syncope).
• Pupil dilation (mydriasis), visual disturbances, ringing in the ears (tinnitus).
• Hair loss.
• Heavy menstrual bleeding.
• Irregular menstruation.
• Weight loss.
• Rapid heartbeat.
• Swelling of upper or lower limbs.
• Nosebleeds.

Rare (may occur in up to 1 out of 1000 people):

• Aggression, depersonalization, hallucinations.
• Slow heartbeat.

Frequency not known (frequency cannot be estimated from available data):

• Decreased sodium blood concentration (manifesting as nausea, malaise, muscle weakness, or confusion).
• Dizziness upon standing due to low blood pressure (orthostatic hypotension).
• Abnormal liver function tests (increased liver enzyme activity in blood).
• Movement disorders (involuntary muscle movements).
• Painful penile erection (priapism).
• Signs of unusual bleeding in the skin and mucous membranes (petechiae).
• Increased secretion of antidiuretic hormone (ADH), causing water retention in the body, blood dilution, and reduced sodium levels (syndrome of inappropriate antidiuretic hormone secretion – SIADH).
• Galactorrhea in men and in women who are not breastfeeding.
• Mania.
• In patients taking medicines of this type, an increased risk of bone fractures has been observed.
• Changes in heart rhythm (known as "QT interval prolongation", visible on ECG, in the electrical activity of the heart).
• Severe vaginal bleeding occurring shortly after childbirth (postpartum haemorrhage); for more information, see section 2 "Pregnancy, breastfeeding and fertility".

In addition, adverse reactions known to occur with medicines having a similar mechanism of action to escitalopram (the active substance in Escitalopram Grindeks) include:

• Psychomotor restlessness (akathisia).
• Loss of appetite.

Reporting of adverse reactions
If any adverse reactions occur, including any not listed in this leaflet, inform your doctor or pharmacist.
Adverse reactions can be reported directly to the Department of Monitoring Adverse Reactions of Medicinal Products at the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
Adverse reactions can also be reported to the marketing authorization holder. Reporting adverse reactions helps provide more information on the safety of the medicine.

5. How to store Escitalopram Grindeks

Keep this medicine out of sight and reach of children.
Do not store above 30°C.
Do not use this medicine after the expiry date stated on the carton and blister pack after "EXP".
The expiry date refers to the last day of the stated month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and other information

The active substance is escitalopram. Each film-coated tablet contains escitalopram oxalate, corresponding to 5, 10 or 20 mg of escitalopram.
The other ingredients are:
Core: microcrystalline cellulose (E460), sodium croscarmellose (E468), hypromellose (E464), talc (E553b), colloidal anhydrous silica (E551), magnesium stearate (E470b).
Coating: hypromellose (E464), macrogol, titanium dioxide (E171).

What Escitalopram Grindeks looks like and contents of the pack
Escitalopram Grindeks 5 mg is a white to off-white, round, film-coated tablet, approximately 6 mm in diameter, biconvex.
Escitalopram Grindeks 10 mg is a white to off-white, oval, film-coated tablet, approximately 8 mm by 6 mm, biconvex, with the markings "1" and "0" on either side of the break line on one side.
Escitalopram Grindeks 20 mg is a white to off-white, oval, film-coated tablet, approximately 12 mm by 7 mm, biconvex, with a break line on one side.

Escitalopram Grindeks is available in blister packs made of PVC/PE/PVdC//aluminium or in blister packs made of OPA/aluminium/PVC//aluminium, containing 14, 28, 30, 56, 98 or 100 film-coated tablets.
Not all pack sizes may be marketed.

Marketing Authorisation Holder
AS GRINDEKS
Krustpils iela 53, Rīga, LV-1057, Latvia
Tel.: +371 67083205
Fax: +371 67083505
E-mail: [email protected]

Manufacturer/Importer
HBM Pharma s.r.o.
Sklabinská 30, 036 80 Martin, Slovakia
AS GRINDEKS
Krustpils iela 53, Rīga, LV-1057, Latvia
Tel.: +371 67083205
Fax: +371 67083505
E-mail: [email protected]

This medicinal product is authorised in the following names in the European Economic Area countries:
Austria Escitalopram Grindeks 5 mg, 10 mg, 20 mg Filmtabletten
Belgium Escitalopram Grindeks 5 mg, 10 mg, 20 mg comprimés pelliculés
Bulgaria Есциталопрам Гриндекс 5 mg, 10 mg, 20 mg филмирани таблетки
Escitalopram Grindeks 5 mg, 10 mg, 20 mg film-coated tablets
Croatia Escitalopram Grindeks 5 mg, 10 mg, 20 mg filmom obložene tablete
Czech Republic Escitalopram Grindeks
Estonia Escitalopram Grindeks
France ESCITALOPRAM GRINDEKS 5 mg, comprimé pelliculé
ESCITALOPRAM GRINDEKS 10 mg, comprimé pelliculé sécable
ESCITALOPRAM GRINDEKS 20 mg, comprimé pelliculé sécable
Greece Escitalopram/Grindeks 5 mg, 10 mg, 20 mg επικαλυμμένα με λεπτό υμένιο δισκία
Spain Escitalopram Grindeks 5 mg, 10 mg, 20 mg comprimidos recubiertos con película
Netherlands Escitalopram Grindeks 5 mg filmomhulde tabletten
Escitalopram Grindeks 10 mg filmomhulde tabletten
Escitalopram Grindeks 20 mg filmomhulde tabletten
Ireland Escitalopram Grindeks 5 mg, 10 mg, 20 mg film-coated tablets
Lithuania Escitalopram Grindeks 5 mg plėvele dengtos tabletės
Escitalopram Grindeks 10 mg plėvele dengtos tabletės
Escitalopram Grindeks 20 mg plėvele dengtos tabletės
Luxembourg Escitalopram Grindeks 5 mg, 10 mg, 20 mg filmbeschichtete Pëllen
Latvia Escitalopram Grindeks 5 mg, 10 mg, 20 mg apvalkotās tabletes
Germany Escitalopram Grindeks 5 mg, 10 mg, 20 mg Filmtabletten
Norway Escitalopram Grindeks
Poland Escitalopram Grindeks
Portugal Escitalopram Grindeks 5 mg, 10 mg, 20 mg comprimidos revestidos por película
Romania Escitalopram Grindeks 5 mg, 10 mg, 20 mg comprimate filmate
Slovakia Escitalopram Grindeks 5 mg, 10 mg, 20 mg filmom obalené tablety
Slovenia Escitalopram Grindeks 5 mg, 10 mg, 20 mg filmsko obložene tablete
Sweden Escitalopram Grindeks
Hungary Escitalopram Grindeks 5, 10 és 20 mg filmtabletta
Italy Escitalopram Grindeks